Skip to main content
Livermore
Livermore
ZHEN

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Intra-Cellular Therapies, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ITCI: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders3354346+15
Shares89.6M211.1K88.9M−468.1K (−0.5%)
Value$6.42B$15.1M$6.15B−$251.0M (−3.9%)

4 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (55)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ITCI in Q1 2024
InstitutionSharesValue% of portfolio
BNP PARIBAS ASSET MANAGEMENT Holding S.A.265,597$18.4M0.05%
Farallon Capital Management, L.L.C.231,000$16.0M0.09%
Point72 Asset Management, L.P.173,766$12.0M0.03%
Walleye Capital LLC155,138$10.7M0.12%
PFM Health Sciences, LP98,879$6.84M0.34%
HAP Trading, LLC68,011$4.71M1.46%
Affinity Asset Advisors, LLC50,000$3.46M0.56%
Granahan Investment Management Inc49,974$3.46M0.12%
Axiom Investors LLC38,845$2.69M0.02%
Danske Bank A/S37,700$2.61M0.01%
CIBC World Markets Corp25,000$1.73M0.01%
Cinctive Capital Management LP23,100$1.60M0.08%
Royce & Associates LP22,500$1.56M0.01%
Cookson Peirce & Co Inc22,383$1.55M0.08%
LMR Partners LLP20,960$1.45M0.04%
Campbell & CO Investment Adviser LLC18,431$1.28M0.11%
Graham Capital Management, L.P.17,107$1.18M0.03%
Y-Intercept (Hong Kong) Ltd16,304$1.13M0.09%
Acuta Capital Partners, LLC13,300$920.4K0.60%
Fred Alger Management, LLC12,534$867.4K0.00%
Silphium Asset Management Ltd10,000$692.0K0.36%
OmniStar Financial Group, Inc.9,711$672.0K0.62%
Jennison Associates LLC9,212$637.5K0.00%
Pearl River Capital, LLC8,089$559.8K0.09%
Inceptionr LLC7,575$524.2K0.13%
SageView Advisory Group, LLC15,196$495.9K0.03%
Engineers Gate Manager LP6,152$425.7K0.01%
Boothbay Fund Management, LLC5,700$394.4K0.01%
ClariVest Asset Management LLC4,970$343.9K0.04%
Cynosure Management, LLC4,594$317.9K0.06%
Wolverine Trading, LLC4,517$312.6K0.00%
Sherbrooke Park Advisers LLC3,911$270.6K0.05%
Maverick Capital LtdSuperinvestorMaverick Capital3,660$253.3K0.00%
Cyrus J. Lawrence, LLC3,550$245.0K0.05%
NEOS Investment Management LLC3,388$234.4K0.01%
Gsa Capital Partners LLP3,353$232.0K0.02%
Central Pacific Bank - Trust Division3,350$228.7K0.03%
Worth Venture Partners, LLC3,300$228.4K1.59%
Cipher Capital LP3,179$220.0K0.10%
Cetera Investment Advisers2,935$203.1K0.00%
Verition Fund Management LLC2,912$201.5K0.00%
Beacon Pointe Advisors, LLC2,911$201.4K0.00%
Leonteq Securities AG2,180$150.9K0.02%
Allianz SE850$58.8K0.00%
Quest Partners LLC728$50.4K0.01%
Headlands Technologies LLC468$32.4K0.01%
Annis Gardner Whiting Capital Advisors, LLC262$18.1K0.01%
Rise Advisors, LLC188$13.0K0.01%
Front Row Advisors LLC133$9.20K0.00%
Meeder Asset Management Inc84$5.81K0.00%
Mather Group, LLC.75$5.37K0.00%
Exchange Traded Concepts, LLC55$3.81K0.00%
IFP Advisors, Inc17$1.18K0.00%
Rothschild Investment LLC10$6920.00%
Continuum Advisory, LLC6$3930.00%

Sold out (40)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ITCI in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Polar Capital Holdings Plc928,745$66.5M
Healthcare of Ontario Pension Plan Trust Fund154,700$11.1M
Ally Bridge Group (NY) LLC141,348$10.1M
J. Goldman & Co LP106,080$7.60M
TD Asset Management Inc72,648$5.20M
EAM Investors, LLC67,143$4.81M
Lighthouse Investment Partners, LLC62,450$4.47M
Tudor Investment Corp Et Al51,555$3.69M
EAM Global Investors LLC50,401$3.61M
Jefferies Financial Group Inc.29,000$2.08M
Marshall Wace, LLP24,249$1.74M
Weiss Multi-Strategy Advisers LLC17,910$1.28M
Zacks Investment Management15,569$1.12M
Jump Financial, LLC14,600$1.05M
Jackson Creek Investment Advisors LLC14,125$1.01M
HRT Financial LP13,767$985.0K
ExodusPoint Capital Management, LP11,895$852.0K
Nebula Research & Development LLC8,631$618.2K
Alpha DNA Investment Management LLC8,147$583.5K
Virtu Financial LLC7,623$546.0K
Mach-1 Financial Group, Inc.7,180$514.2K
AE Wealth Management LLC7,326$493.6K
Penserra Capital Management LLC5,951$426.0K
Atom Investors LP4,944$354.1K
Shikiar Asset Management Inc3,500$251.0K
Fox Run Management, L.L.C.3,289$235.6K
Deerfield Management Company, L.P. (Series C)2,910$208.4K
Torno Capital, LLC1,500$107.4K
Cape Investment Advisory, Inc.1,085$77.7K
nVerses Capital, LLC–$71.6K
Advisory Services Network, LLC442$31.7K
McGlone Suttner Wealth Management, Inc.332$23.8K
Cutler Group LP300$21.0K
Lee Financial Co260$18.6K
West Tower Group, LLC226$16.2K
Raleigh Capital Management Inc.107$7.66K
Macroview Investment Management LLC106$7.59K
Carolinas Wealth Consulting LLC14$977
Able Wealth Management LLC9$645
Ronald Blue Trust, Inc.7$0

Not filed for Q1 2024 yet (4)

Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITCI in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Putnam Investments LLC195,072$14.0M
Vahanian & Associates Financial Planning Inc.9,917$710.3K
AtonRa Partners5,772$413.4K
Coppell Advisory Solutions LLC309$22.1K